Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease

被引：0
|
作者：
Iskra Pusic
Catherine Lee
Muthu Veeraputhiran
Chelsea Minor
John F. DiPersio
机构：
[1] Washington University School of Medicine,Fred Hutchinson Cancer Center
[2] Division of Oncology,undefined
[3] Clinical Research Division,undefined
[4] University of Arkansas for Medical Sciences,undefined
[5] Department of Hematology and Medical Oncology,undefined
来源：
Bone Marrow Transplantation | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：282 / 284
页数：2
相关论文
共 50 条
  • [41] RUXOLITINIB FOR TREATMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE: A SINGLE CENTER RETROSPECTIVE ANALYSIS
    Denk, Alexander
    Weber, Daniela
    Holler, Ernst
    Meedt, Elisabeth
    Fante, Matthias
    Mittermaier, Cornelia
    Poeck, Hendrik
    Herr, Wolfgang
    Edinger, Matthias
    Wolff, Daniel
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 327 - 327
  • [42] Ruxolitinib for Therapy of Graft-versus-Host Disease
    Neumann, Thomas
    Schneidewind, Laila
    Weigel, Martin
    Plis, Andrzej
    Vaizian, Rem
    Schmidt, Christian A.
    Krueger, William
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [43] Belumosudil for the treatment of chronic graft-versus-host disease: a single center real-world experience
    Modi, Badri
    Ngo, Dat
    Chen, Jason
    Yang, Dongyun
    Shan, Haoyue
    Sandhu, Karamjeet
    Rashid, Nahid
    Amanam, Idoroenyi
    Otoukesh, Salman
    Nakamura, Ryotaro
    Ali, Haris
    Salhotra, Amandeep
    BONE MARROW TRANSPLANTATION, 2025, 60 (04) : 555 - 557
  • [44] Ruxolitinib for Acute Graft-versus-Host Disease
    Gratwohl, Alois
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05): : 501 - 501
  • [45] Ruxolitinib for therapy of graft-versus-host disease
    Plis, A.
    Neumann, T.
    Schneidewind, L.
    Weigel, M.
    Vaizian, R.
    Schmidt, C.
    Krueger, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 205 - 205
  • [46] TWO-CENTER EXPERIENCE IN THE TREATMENT OF RUXOLITINIB FOR ACUTE AND CHRONIC GLUCOCORTICOID-REFRACTORY GRAFT-VERSUS-HOST DISEASE
    Eloi, Canamero
    Mireia, Morgades
    Rocio, Parody
    Maria Josefa, Jimenez
    Meriem, Kara
    Anna, Torrent
    Andrea, Espasa
    Martina, Comes
    Cristina, De la Fuente
    David, Quintela
    Maria, Huguet
    Rebeca, Jurado
    Alejandro, De Jaureguizar
    Marta, Canelo
    Anna, Sureda
    Josep Maria, Ribera
    Christelle, Ferra
    HAEMATOLOGICA, 2021, 106 (10) : 277 - 278
  • [47] Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease
    Khoury, Hanna Jean
    Langston, Amelia A.
    Kota, Vamsi K.
    Wilkinson, Jennifer A.
    Pusic, Iskra
    Jillella, Anand
    Bauer, Stephanie
    Kim, Audrey S.
    Roberts, Danielle
    Al-Kadhimi, Zaid
    Bodo, Imre
    Winton, Elliott
    Arellano, Martha
    DiPersio, John F.
    BONE MARROW TRANSPLANTATION, 2018, 53 (07) : 826 - 831
  • [48] Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease
    Hanna Jean Khoury
    Amelia A. Langston
    Vamsi K. Kota
    Jennifer A. Wilkinson
    Iskra Pusic
    Anand Jillella
    Stephanie Bauer
    Audrey S Kim
    Danielle Roberts
    Zaid Al-Kadhimi
    Imre Bodo
    Elliott Winton
    Martha Arellano
    John F. DiPersio
    Bone Marrow Transplantation, 2018, 53 : 826 - 831
  • [49] Beyond ruxolitinib in steroid-refractory acute graft-versus-host disease
    Lee, Catherine J.
    Pusic, Iskra
    Savani, Bipin N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 306 - 307
  • [50] Ruxolitinib for steroid-refractory graft-versus-host disease: A case series
    Lancman, Guido
    Coltoff, Alexander
    Steinberg, Amir
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (03) : 611 - 613
12345